Companies on Diabetes and Endocrinology

Published within

« | 1 | 2 | 3 | » »|

Type Product title / description Pub Price
Company Profile
Company Profile

Amylin Pharmaceuticals, LLC

Amylin Pharmaceuticals, LLC (Amylin or 'the company'), a wholly-owned subsidiary of Bristol-Myers Squibb (BMS), is a biopharmaceutical company engaged in the development of potential therapies to treat diabetes and obesity. Amylin currently markets Byetta, Symlin and Bydureon for the treatment of diabetes. The company primarily operates in the US, where it is headquartered in San Diego, California. It employed about 1,300 people as of December 31, 2011.

Published By MarketLine
08 Jan 2013 $175
Buy
Company Profile
Company Profile

Rigel Pharmaceuticals, Inc.

Rigel Pharmaceuticals (Rigel or 'the company') is a clinical-stage drug development company engaged in the discovery and development of small-molecule drugs for the treatment of inflammatory and autoimmune disorders, as well as muscle disorders. The company operates in the US, where it is headquartered in South San Francisco, California. It employed 157 people as of December 31, 2012.

Published By MarketLine
29 Oct 2013 $175
Buy
Company Profile
Company Profile

BioMarin Pharmaceutical Inc.

BioMarin Pharmaceutical (BioMarin or 'the company'), a commercial-stage biopharmaceutical company, develops and commercializes biopharmaceuticals for the treatment of serious diseases and medical conditions. The company operates in the US, Europe and Latin America. It is headquartered in San Rafael, California, and employed 1,089 people as of January 4, 2013.

Published By MarketLine
27 Nov 2013 $175
Buy
Company Profile
Company Profile

Depomed, Inc.

Depomed, Inc. (Depomed or 'the company') is a specialty pharmaceutical company focused on the development and commercialization of differentiated products that are based on oral drug delivery technologies. The company primarily operates in the US. Depomed is headquartered in Menlo Park, California, and employed 267 people as of February 20, 2013.

Published By MarketLine
27 Nov 2013 $175
Buy
Company Profile
Company Profile

Merck KGaA

Merck KGaA (or 'the group') is a leader in pharmaceutical, chemical and life science. The group offers branded prescription drugs, and chemicals for high-tech applications. The Merck family holds an approximately 70% interest in the group and shareholders own the remaining approximately 30%. The group operates in 66 countries across the world. It is headquartered in Darmstadt, Germany and employed 38,847 people as of December 31, 2012.

Published By MarketLine
05 Dec 2013 $175
Buy
Company Profile
Company Profile

Isis Pharmaceuticals, Inc.

Isis Pharmaceuticals (Isis or 'the company') uses antisense technology, a drug discovery platform, to discover and develop novel drugs for its product pipeline and for its partners. The company primarily operates in the US. It is headquartered in Carlsbad, California, and employed 288 people as of February 11, 2013.

Published By MarketLine
08 Jan 2014 $175
Buy
Company Profile
Company Profile

Ono Pharmaceutical Co., Ltd.

Ono Pharmaceutical (Ono or 'the company') is primarily engaged in the manufacture and sale of pharmaceuticals. The company operates in Japan, other parts of Asia, Europe and the US. It is headquartered in Osaka, Japan, and employed 2,807 people as on March 31, 2013.

Published By MarketLine
13 Feb 2014 $175
Buy
Company Profile
Company Profile

Mitsubishi Tanabe Pharma Corporation

Mitsubishi Tanabe Pharma (Mitsubishi Tanabe or 'the company') is engaged in the manufacture and sale of ethical pharmaceuticals. The company primarily operates in Japan, where it is headquartered in Osaka. It employed 8,835 people as on March 31, 2013.

Published By MarketLine
21 Feb 2014 $175
Buy
Company Profile
Company Profile

Shionogi & Co., Ltd.

Shionogi & Co. (Shionogi or 'the group') is engaged in the research, development, manufacture, and marketing of ethical drugs, over-the-counter drugs and diagnostic products. Shionogi operates in Japan, Europe, North America and other regions of the world. It is headquartered in Osaka, Japan, and employed 6,082 people as on March 31, 2013.

Published By MarketLine
25 Feb 2014 $175
Buy
Company Profile
Company Profile

Dr. Reddy's Laboratories Limited

Dr. Reddy's Laboratories (DRL or 'the company') is an integrated global pharmaceutical company. The company primarily operates in India, North America, Europe, Russia and other countries of the former Soviet Union. It is headquartered in Hyderabad, India, and employed 16,617 people as on March 31, 2013.

Published By MarketLine
25 Feb 2014 $175
Buy

« | 1 | 2 | 3 | » »|

No help is available.